State-of-the-art cerium nanoparticles as promising agents against human viral infections

Biomed Pharmacother. 2022 Dec:156:113868. doi: 10.1016/j.biopha.2022.113868. Epub 2022 Oct 15.

Abstract

The world is faces a significant global health challenge in the form of viral infections, particularly the emergence of viral strains that are resistant to effective antiviral therapies. This underscores the urgent need for the development of effective and safe antiviral agents. Nanoscale materials are now being used as novel antiviral agents. Cerium nanoparticles have unique chemical and physical properties that make them particularly promising for viral infections. These particles reduce inflammation and the autoimmune response. Cerium nanoparticles, in addition to their antiviral properties, have many other advantages that are highly sought after for various aspects of biomedical applications. This review focuses on the various properties of cerium nanoparticles as a novel agent against viral infections.

Keywords: Adjuvant; Cerium nanoparticle; Vaccine; Viral Infections.

Publication types

  • Review

MeSH terms

  • Antioxidants / chemistry
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Cerium* / pharmacology
  • Cerium* / therapeutic use
  • Humans
  • Nanoparticles* / chemistry
  • Virus Diseases* / drug therapy

Substances

  • Cerium
  • Antioxidants
  • Antiviral Agents